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ABSTRACT
Background Pain is very common in childhood emergency 
department (ED) attendances, but is under- recognised and 
undertreated. Sequential national paediatric analgesia audits 
demonstrate suboptimal outcomes in several domains. The 
Donabedian framework examines the structures, processes 
and outcomes to evaluate quality of care. To date there has 
been no network- level exploration of structures supporting 
analgesic practices or attempts to address failure to attain 
national standards.
Objective To benchmark current variation in assessment 
and management of childhood pain at network level.
Methods Online survey distributed between December 
2016 and January 2017 exploring health system structures 
including pain score tools, pain assessment/protocols, 
training, practice guidelines and analgesic agent usage. We 
explored structures, processes and outcomes to identify 
interventions, and their potential effectiveness and feasibility.
Results In total 95% (38/40 sites) responded, including 25 
tertiary (66%) and 13 secondary hospitals (34%), with a total 
annual paediatric ED census of 1 225 000 (range 11 500–65 
000). Availability of analgesics varied included topical wound 
anaesthesia in 29/38 sites (76%), oral diclofenac sodium in 
22/38 sites (58%) and tramadol in 16/38 sites (42%). Pain 
assessment was mandatory in initial assessment in 34/38 
sites (89%), and 18/38 sites had a policy on frequency of 
pain assessment (47%). Local guidance aligned with national 
guidance in 21/38 sites (55%). There was no staff training at 
induction/orientation in 14/38 sites (37%) and no mandatory 
competencies in pain management in 23/38 sites (61%). Play 
specialist services were available in 21/38 sites (55%).
Conclusion Despite national guidance and 
recommendations from multiple audits, there are substantial 
variations in structures relating to pain assessment and 
management across sites. The lack of uniformity is a likely 
root cause for the persistent suboptimal practices identified 
by serial national audits. A whole system and person- centred 
approach to improving pain outcomes by utilising effective 
interventions seeks to improve paediatric pain outcomes.
INTRODUCTION
Pain is present in most childhood trauma 
presentations,1 and in over 60% of all patients 
presenting to emergency departments 
(EDs).2 The extensive short and long- term 
consequences of inadequately treated acute 
pain have led to universal acceptance that 
pain management should begin at the earliest 
opportunity.3 Current standards, there-
fore, recommend simple, timely, sequential 
processes of recognition, assessment, inter-
vention, reassessment and maintenance of 
pain relief.4
The Royal College of Emergency Medi-
cine (RCEM) identified pain management 
as a key indicator of quality of care in EDs;5 
it has subsequently published and revised 
guidelines on pain management in children4 
and developed clinical standards for EDs,6 
also incorporated into ‘Facing the future: 
Standards for children in emergency care 
settings’ by the Intercollegiate Committee.7 
This approach to standardising and 
improving care is reflected in other national 
and international guidelines.3 Seven succes-
sive national audits of ED childhood pain 
management since 2003 have demonstrated 
some improvement in prehospital analgesia 
What is known about the subject?
 ► Multiple prior UK audits of pain assessment and 
management in children demonstrated deficiencies 
in optimal analgesia practices most notably in ade-
quate timely analgesia administration and the reas-
sessment after intervention.
 ► Minimal progress to address the deficiencies high-
lighted in the audits has been demonstrated to date.
What this study adds?
 ► Uniform health system structures and guidance to 
support optimal analgesic practices were lacking 
in the frequency of pain assessment, training and 
competencies in pain management and paediatric 
sedation.
 ► A uniform system for paediatric pain management 
is needed. Potential opportunities for network- wide 
improvement include mandated early pain assess-
ment with timely analgesia administration and man-
dated reassessment.
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(29% in 2017/2018 audit), and in recording of pain 
score on arrival (national median of 12% in 2003 to 55% 
in 2017/2018).8 However, continued deficiencies persist 
in timely management of pain in patients with moderate 
and severe pain,8 and most notably a near complete 
absence of pain re- evaluation after administering anal-
gesia. The three components approach (structures, 
processes and outcomes) for evaluating quality of care9 
underpins measurement for improvement. Structures 
(physical and organisational characteristics where 
healthcare occurs) affect process measures, which affects 
outcome measures.10 Understanding structures is funda-
mental in driving improvement. To date there has been 
no network- level exploration of structures supporting 
analgesic practices, or attempts to address failure to 
attain national standards.
Paediatric Emergency Research in the United Kingdom 
and Ireland (PERUKI) identified acute pain as a research 
priority.11 The vision of this collaboration is knowledge 
creation and implementation to improve emergency care 
of children through robust multicentre research, and 
knowledge translation in the emergency care system. Any 
such research or translation in the quality of paediatric 
pain management can only be delivered once existing 
structures, processes and outcomes are well described.
The aim of this study was to describe system struc-




This study was completed between 16 December 2016 
and 16 January 2017 across PERUKI, a research collabo-
rative representing a mix of tertiary and district general 
hospitals in urban and rural settings. Site lead investiga-
tors completed an online survey which explored service 
structures for acute childhood pain management in their 
ED, with content also pertaining to local guidelines and 
pathways for pain management. Survey content was devel-
oped iteratively based on existing recommendations and 
published literature, with consensus derived in the study 
team where necessary.
The survey consisted of 27 questions including contact 
details, institution characteristics, pain assessment and 
scoring tools, analgesic pathways, medications available, 
information given to patients and carers, education, 
audit and quality improvement performed and other 
aspects of pain management. The survey included single 
and multiple- answer questions to establish the presence 
or absence of relevant elements within each ED. Likert 
5- point scales on frequency, as well as open questions to 
solicit further comments, were used. The full survey is 
available in the online supplemental appendix 1, and 
results are reported in line with the CHERRIES state-
ment (online supplemental appendix 2).12
Data collection and statistical analysis
The survey was distributed using Online Surveys (JISC, 
https://www. onlinesurveys. ac. uk/) and was open for 
1 month; reminders were sent 2 weeks and 1 week before 
the survey closed. Data were analysed using Excel (Micro-
soft Office 365) and responses are presented using 
descriptive statistics, including number and proportion, 
or median as appropriate to the underlying distribu-
tion. Free- text answers were themed and then described 
volumes in each theme are presented.
Patient and public involvement
Patients were not involved in the design, recruitment and 
conduct of the study.
RESULTS
Study responses
Thirty- eight sites responded to the survey from forty 
surveyed (95% response rate). The total annual paedi-
atric attendance across all participating sites was 1 225 
000, ranging from 11 500 to 65 000 (median 30 000); site 
characteristics are described in table 1.
ED pain assessment and management
Pain assessment and scoring during initial assessment 
were mandatory in 34 sites (89%). Pain assessment tools 
used are detailed in figure 1. A median of 3 tools were 
used in each site (range 1–4); the ‘other scale’ category 
comprised assessment tools that were unique and used in 
single sites.
Additional processes or pathways to promote/obligate 
analgesia administration and/or pain score reassessment 
were integrated within 18 sites (47%). They included 
Table 1 Respondent characteristics, n=38
No of sites (%)
Country
  England 30 (79)
  Scotland 3 (8)
  Ireland 3 (8)
  Wales 1 (2.5)
  Northern Ireland 1 (2.5)
Hospital characteristics
  Tertiary centre 25 (66)
  District general hospital 13 (34)
  Trauma centre 20 (53)
  Trauma unit 12 (32)
  Neither trauma unit or trauma centre 6 (15)
  Mixed adult/paediatric hospital with 
separate paediatric ED
15 (39)
  Mixed adult/paediatric hospital with a 
combined ED
11 (29)
  Paediatric hospital 12 (32)
ED, emergency department.
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mandatory pain scoring as a routine observation in seven 
sites (18%), prompts on patient charts to score and 
manage pain in three sites (8%), patient group direction 
(PGD) administration of medication in three sites (8%), 
regular analgesia audits in two sites (5%), mandatory 
pain assessment in triage in two sites (5%) and specific 
guidelines or pathways in two sites (5%).
Guidelines
Twenty- nine sites (76%) had a guideline, 21 (72%) of 
these were in line with RCEM guidance as reported by 
the site lead. Aspects of pain management covered by 
the guidelines are summarised in tables 2 and 3. Eight 
sites (21%) had no current (local) pain management 
guideline; two sites with an annual paediatric census over 
50 000, six sites were tertiary centres, two were district 
general hospital and five were paediatric trauma centres. 
In sites with local guidance, the number of relevant docu-
ments at each site varied from 1 to 6, and the length of 
document ranged from 1 to 134 pages (median length 
8.5 pages).
Pharmacology availability is detailed in table 4. Varia-
tion existed in the availability of medications such as oral 
diclofenac sodium, tramadol and topical wound anaes-
thesia. There was access to ED point- of care ultrasound to 
aid with procedures (eg, nerve blocks) in 34 sites (89%). 
Digital nerve blocks were performed in 37 sites (97%) 
and femoral nerve blocks in 34 sites (89%). Paediatric 
procedural sedation was available in 14 sites (37%).
Patient group directions
PGDs existed in 35 sites (92%). The number of PGDs 
for analgesia at each site varied between 2 and 6 with 
a median of 3. PGDs for paracetamol and ibuprofen 
existed in over 90% of sites, topical anaesthesia in 75%, 
and nitrous oxide/Entonox in 34%. The frequency of 
PGDs for topical wound anaesthesia gel, codeine, oral 
morphine and lidocaine were 11%, 5%, 3% and 3%, 
respectively.
Patient and carer empowerment
At 19 sites (50%), strategies were used to empower 
patients/parents to request analgesia. Parents were 
encouraged either verbally or through visual prompts 
to seek additional analgesia in 18 sites (47%) when 
required. Three sites (8%) gave written information on 
pain/analgesia to paediatric patients and five sites (13%) 
gave information to parents/carers for use while in the 
ED. In 15 sites (39%) written information on pain/anal-
gesia was given to parents/carers on discharge.
Audit, governance and education for pain management
Nine sites (24%) audited pain management in children 
during the preceding year, and 24 sites (63%) within 
the last 5 years. Seventeen sites (45%) made changes 
based on audit results; these focused on reassessment 
Figure 1 Pain assessment tools used across different sites.14
Table 2 Aspects covered in local guidelines in sites where 
guidelines were in line with RCEM,4 n=21
No of sites (%)
Dosages for different ages groups 21 (100)
Use of pain scales 18 (86)
Use of a standardised pain ladder* 18 (86)
Contraindications to specific analgesic 
agents
18 (86)
Monitoring of vital signs with opioid 
analgesia
17 (81)
Non- pharmacological management of pain 15 (71)
Monitoring of sedation level with opioid 
analgesia
14 (67)
Preferred analgesia for specific conditions 12 (57)
Frequency of pain assessment 11 (52)
Discharge criteria after opioid analgesia 11 (52)
Referral process based on pain score 7 (33)
*Pain ladder: contains objective and/or subjective descriptions 
with a numerical scale to quantify pain.
RCEM, Royal College of Emergency Medicine.
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and documentation in 11 sites (29%), improving access 
to assessment tools in two sites (5%), new guidance in 
two sites (5%), new patient leaflets in one site (3%), 
increased PGD administration of medication at triage in 
one site (3%) and mandated pain assessment after triage 
in one site (3%).
Training was included in induction/orientation in 24 
sites (63%), professional development in 16 sites (42%) 
and pain/analgesia competencies were mandatory in 15 
sites (39%). Quality improvement processes relating to 
pain assessment or management were in operation in 
18 sites (47%). These included regular audits of pain 
scoring and analgesia administered, the development 
of new guidelines/policies/protocol to improve areas of 
practice and increased training of staff.
Non-pharmacological management
There was restricted access to a play specialist in 21 sites 
(55%); the remaining sites had no access. The median 
number of items for distraction or entertainment was 
3.5 (range 1–8, figure 2). Other items reported included 
different modalities for light and/or sensory distraction 
in nine sites (24%).
Immobilisation strategies employed for traumatic inju-
ries prior to clinician assessment varied. Arm slings were 
applied very frequently/frequently in most sites (29 sites, 
76%), though Futura splints were not applied/infre-
quently applied in most sites (32 sites, 84%).
DISCUSSION
We have described the structures relating to paediatric 
pain management across an international paediatric 
emergency network, and identified significant variations 
contributing to processes and outcomes in paediatric 
pain management.10 Variations included guideline avail-
ability and content, staff education, pain reassessment, 
pain scale usage, pharmacological accessibility, PGD 
usage and procedural sedation availability. Variation 
Table 4 Pharmacology availability
Medications No of sites (%)
Oral route
  Ibuprofen 38 (100)
  Paracetamol 38 (100)
  Morphine 38 (100)
  Sucrose 32 (84)
  Codeine 26 (68)
  Diclofenac sodium 22 (58)
  Tramadol 16 (42)
  Dihydrocodeine 3 (8)
Intravenous route
  Morphine 38 (100)
  Paracetamol 35 (92)
  Ketamine 30 (79)
  Propofol 24 (63)
  Fentanyl 24 (63)
Rectal route
  Paracetamol 38 (100)
  Diclofenac sodium 29 (76)
Other routes
  Intranasal—diamorphine/fentanyl 38 (100)
  Inhaled—nitrous oxide/entonox 38 (100)
  Topical anaesthesia (eg, tetracaine, 
lidocaine±prilocaine)
38 (100)
  Topical wound anaesthesia (eg, lidocaine, 
epinephrine and tetracaine gel, tetracaine, 
epinephrine and cocaine gel)
29 (76)
Figure 2 Amenities and equipment available to assist with non- pharmacological analgesia. DVD, digital video disc; TV, 
television.
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existed in non- pharmacological approaches, including 
distraction amenities, parental empowerment and access 
to play services.
The aim of timely, efficient and adequate pain manage-
ment is not being achieved in EDs despite multiple sequen-
tial audits, with deterioration in timeliness of treatment 
being demonstrated in the most recent national audit of 
patients with moderate and severe pain.8 A recent UK 
study identified that other ED tasks were prioritised over 
pain management if this was not aligned with department 
core priorities, and not perceived as a key organisational 
priority for which staff were held accountable.13 When 
recommending interventions one must consider a hier-
archy of effectiveness, and each solution’s level of feasi-
bility. A systematic review and narrative synthesis of ED 
interventions to improve pain management revealed it 
was impossible to estimate effectiveness of interventions, 
or identify which had the greatest impact.14 A hierarchy 
of intervention effectiveness in EDs has been described, 
with forcing functions having highest effectiveness, 
and education or personal initiative/vigilance having 
the lowest.15 Medication safety literature demonstrates 
system based interventions are the most effective, with 
highest leverage, but are the least feasible; conversely, 
person- based interventions are least- effective, with lowest 
leverage, but are most feasible.16
Results demonstrated that 1/4 of paediatric hospi-
tals and trauma centres, and 1/3 of hospitals with an 
annual paediatric ED attendance over 50 000, did not 
have local guidance to support best practice in paediatric 
pain management. In previous studies, introducing pain 
protocols and education in EDs have improved analgesia 
provision, including usage of intravenous analgesia.17 
National guidance4 and standards6 which promote opti-
mised pain assessment and management need to be 
implemented uniformly, as failure to do so commonly 
leads to oligoanalgesia.18 In EDs, this should be interdisci-
plinary, with clear lines of responsibility for achieving and 
measuring pain control. Multimodal pain management 
strategies are needed to minimise pain and discomfort 
that incorporate a combination of pain control strate-
gies, such as opioids, non- steroidal anti- inflammatory 
drugs and non- pharmacological interventions.19 The 
uniform implementation of a single national guideline is 
a potentially moderately effective intervention, through 
simplification and standardisation of pain management 
across the health system.
Education varied in content, availability and strategy 
across sites. Under half delivered formal professional 
training in pain management, or mandated pain/anal-
gesia competencies, implying that pain education is a low 
priority for over 50% of responding sites. Education and 
training are essential in enabling effective pain manage-
ment,18 and knowledge acquisition through mandated 
training could be targeted at a national or network 
level. This intervention is likely moderately effective, 
and highly feasible, especially if delivered from post- 
graduate training institutions. To optimise the feasibility 
of such a strategy, it is essential to simplify practices and 
content. For example, ten different pain scales were in 
use, a factor which is a potential threat to any national 
training package given the lack of translation between 
institutions. Simplifying by reducing the volume, and 
standardising pain tool usage, is a medium leverage 
and moderately effective intervention. Coupling these 
strategies align well with existing literature, as previous 
evidence- based knowledge translation interventions 
demonstrates sustained improvement in paediatric pain 
practices.20
Assessment and reassessment of pain are central to opti-
mising pain management, but given current constraints 
on healthcare systems, reassessment of any condition or 
symptom in stable patients, including pain, is often the 
most challenging element of care. Pain is reassessed in 
only 15% of ED patients nationally.8 There is significant 
positive association between documentation of a pain 
score and subsequent use of any analgesic,21 and the 
converse is also true.18 One moderate to highly effective 
system- based intervention is alerts using the electronic 
triggers in ED information systems for pain reassessment. 
Using technology to engage parents in acute pain care, 
including reassessment, may improve the child’s experi-
ence, increase parental satisfaction and reduce anxiety.22
A large difference in the quantities of non- 
pharmacological analgesia resources across sites existed. 
Level 1 evidence from systematic reviews/meta- analysis 
of relevant randomised trials demonstrated that non- 
pharmacological analgesia reduces pain,3 and Intercolle-
giate guidelines therefore state all EDs that treat children 
should employ a play specialist.7 This method of pain 
control is often overlooked, and sites should prioritise 
incorporating this as a priority. The forcing function 
of mandating such an intervention is most effective in 
achieving a successful change and may not be a huge 
burden when one considers the cost and availability of 
smart devices.
Local accessibility to medications, practices, and atti-
tudes effect optimal practice.18 There was widespread 
access to intranasal opioids and nitrous oxide/Entonox. 
Intranasal opioids have gained increased popularity over 
intravenous opioids due to their fast onset, safety and ease 
of administration.23 RCEM guidelines advocate diclofenac 
sodium, codeine or oral morphine for moderate pain.4 
Since 2013, this has become more limited as codeine is 
contraindicated in children under 12 years due to the risk 
of toxicity.24 Morphine can require incremental dosing 
with frequent pain reassessment to achieve optimal anal-
gesia due to the risk of respiratory depression. Barriers 
to the routine use of morphine include opiophobia and 
monitoring requirements.24 Intranasal fentanyl is equiva-
lent to intravenous/intramuscular morphine in reducing 
pain associated with acute paediatric fracture in the ED 
and internal evidence where it was incorporated into a 
triage protocol demonstrated earlier onset analgesia 
compared with intravenous opioids.3 We suggest bodies 
producing national guidance include drugs suitable for 
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intranasal administration for moderate to severe pain. 
Other alternatives including inhaled methoxyflurane3 
may become future additions following completion of 
randomised controlled trials.
Modifying organisational infrastructure to remove 
barriers is crucial. The universal implementation of PGDs 
could yield a moderately effective solution. These enable 
administration of specified prescription- only medicines 
to groups of patients under an overarching prescription, 
removing the need for individual- level prescription every 
time, with consequent reductions in time to analgesia.25 
Single- checked PGDs are used successfully in many paedi-
atric EDs without increasing rates of medication errors.25 
Broadening their use and incorporating nurse- led proto-
cols are likely to reduce time to analgesia and improve 
pain assessment.21
We have described current pain management struc-
tures in paediatric emergency care at a network level, 
and provided an insight into acute paediatric pain 
management. Variation is high, which likely contrib-
utes to poor pain outcomes identified in national 
audits. We, therefore, recommend person- centred 
and whole system interventions, of varying effective-
ness, addressing these structural variations, to improve 
pain outcomes for children attending EDs which are 
summarised in box 1.
LIMITATIONS
This survey relied on accurate reporting by one clini-
cian at each site based on our designed survey. These 
reports are unverified and are a single person’s views of 
each department which may over- report or under- report 
certain aspects. The results of compliance of guidelines 
to RCEM standards are reported based on the site leads 
interpretation and the guidelines sent to the study team 
were not analysed to verify this. Our approach allowed 
us to gain insight into many sites across the network, and 
our response rate means we are confident we identified 
key variations. We identified variation in practice, but we 
cannot determine best practice. We did not seek informa-
tion on the prehospital management of pain, the qualifi-
cations of staff who assess and administer analgesia, staff 
motivations regarding pain assessment and management 
or documentation in medical records in our survey. This 
limits the ability to fully evaluate the structures of health-
care in the sites.
CONCLUSIONS
Controlling pain is a cornerstone of compassionate care. 
There has been serial and widespread documentation 
of the substandard pain outcomes currently provided 
in the management of acute pain in children. A revised 
and effective approach is needed. This survey has iden-
tified an opportunity for structural improvements to 
support the current national guidance for the manage-
ment of pain in children.4 Potential opportunities for 
network- wide improvement include uniform guidance 
to mandate early pain assessment with timely effective 
analgesia administration and mandated reassessment. 
Other key areas for improvement include staff training 
and competencies, non- pharmacological analgesia and 
increasing the number of PGD medications and single- 
checked PGDs.
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